- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05163769
Physical and Cognitive Training System for Neurocognitive Protection and Enhancement in Older Adults
The Efficacy of a Novel Multimodal Personalized Physical and Cognitive Training System for Neurocognitive Protection and Enhancement in Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Neurocognitive decline is a health problem that is associated with ageing. More often than not, age-related cognitive decline may be indicative of the onset of mild cognitive impairment (MCI), or even more severe neurocognitive disorders such as Alzheimer's and Parkinson's disease-both of which will eventually lead to dementia. Cognitive decline and neurocognitive disorders can often lead to the gross deterioration in one's quality of life. Depending on the severity and duration of the onset of the neurocognitive decline, patients may experience anything from forgetfulness or learning difficulties, to major issues such as a decreased capacity for decision-making, confusion, disorientation, communication problems, and social behavioral issues. All of these issues could impede one's ability to care for one's self, which may also lead to the increased reliance and burden on caretakers.
On a global scale, it is estimated that about 46.8 million people suffer from dementia or other dementia subtypes. That number is expected to increase by 68% over the next 30 years. The current economic burden of dementia and other dementia subtypes is evaluated at $818 billion, with projections expecting cost to rise to $2 trillion by the year 2030. In Singapore specifically, the estimated cost of dementia was reported at $1.4 billion per year, with costs expecting to rise in tandem with Singapore's rapidly aging population. Given the impact and impending threats of neurocognitive decline, it is clear that intentional efforts to combat neurocognitive decline is necessary.
To date, experts in the field have yet to identify specific causes of neurocognitive decline. This is due to the heterogeneity of neurocognitive decline and the diseases associated with it. As such, it has been challenging to find definitive causes and cures for neurocognitive decline. That said, there are several risk factors associated with neurocognitive decline and dementia. Risk factors such as age and genetics are fairly predictive of neurocognitive decline, but are, by nature, unmodifiable. However, risk factors such as, but not limited to, cardiovascular problems, physical activity, cognitive training, and social engagement are possible and much easier to modify. Hence, there has been a preponderance of interventions in the field that targets those specific modifiable risk factors with the intention of manipulating current or future neurocognitive outcomes. For example, cognitive training (CT) has been a target for interventions that promote the delay and/or prevention of neurocognitive decline. Over the past few decades, CT programs in the field have evolved to computerized, gamified, and self-manned versions that usually target specific areas of cognition such as memory, attention, decision-making, inhibition, or a combination of those areas.
Similarly, physical activity (PA) has also been a target for interventions that promote the delay and/or prevention of neurocognitive decline. Studies with PA-specific interventions have also shown to positively influence neurocognitive function in patients with mild cognitive impairment, as well as those who are at risk of developing Alzheimer's Disease. Evidence also show that PA can delay the effects of neurocognitive decline in patients with existing cognitive decline, dementia, and other dementia subtypes.
Interestingly, there has been a recent surge of interventions in the field that amalgamates both PA and CT elements. This shift in direction in the field acknowledges the symbiotic relationship between CT and PA with regards to neurocognitive outcome. Many of these studies set out to investigate the effects of 'exergaming' (a portmanteau of exercise and gaming) on neurocognitive function in the older adult population with varying neurocognitive capacity ranging from healthy to declining. Exergaming interventions have shown to improve the subjects' executive function and cognitive performance after the intervention period as compared to the subject controls. The effects of exergaming interventions were also able to delay the onset of mild cognitive impairment in healthy subjects as compared to the healthy controls in some studies. That said, such programs are still limited by factors such as poor personalization capabilities, substandard controls, and high attrition rates (lack of participant engagement). Additionally, studies of such nature are far and few between in Asia, making it unclear if similar results can be replicated in an Asian-majority demographic like Singapore.
To address these issues, the current study aims to use a novel personalized multimodal physical and cognitive brain computer interface (BCI) training system to delay and/or prevent neurocognitive decline, and enhance neurocognitive function. The investigators' proposed training system integrates a stationary cycling intervention and a corresponding personalized BCI cognitive training program. The BCI cognitive training program uses machine learning technologies and elderly-friendly user-interface/user-experience (UI/UX) game design to actively track individual neurocognitive status, provide feedback in real-time, and encourage older adults to persist in training for the long term. The investigators also seek to customize the program's UI/UX by employing locally-relevant materials to reduce accessibility barriers and increase participant engagement. For the purposes of this study, all instructions and interventions will be delivered in English. However, there are plans for future iterations of this program to include other local languages to facilitate the use of the program by non-English speaking Singaporean elderly.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Melissa Ng, BSc
- Phone Number: +65 90272218
- Email: melissa.ng@duke-nus.edu.sg
Study Contact Backup
- Name: Tih Shih Lee, MD/PhD
- Phone Number: +65 65161766
- Email: tihshih.lee@duke-nus.edu.sg
Study Locations
-
-
-
Singapore, Singapore, 169857
- Recruiting
- Duke-NUS Graduate Medical School
-
Contact:
- Melissa Ng
- Phone Number: +65 65161766
- Email: melissa.ng@duke-nus.edu.sg
-
Principal Investigator:
- Tih Shih Lee, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Physically healthy adults from 50 to 75 years old.
- Mini-mental state examination (MMSE) >= 24.
- Able to travel to study site independently.
- Literate in English.
- BMI within acceptable range (BMI scores from 18.5 to 24.9).
- Able to cycle on the NeeuroCycle recumbent bicycle device at a comfortable pace for a continuous period of three minutes without experiencing symptoms of severe breathlessness, fatigue, and pain.
- Fully vaccinated against COVID-19 (Government Approved Vaccines ONLY; at least two weeks from the date of the second vaccination)
Exclusion Criteria:
- Any known neuropsychiatric disorders (such as dementia, epilepsy or mental retardation).
- Presence of end stage lung, cardiac, liver, and/or renal disease.
- Experienced any cerebrovascular and/or cardiac events in the last 6 months.
- Have active arthritis.
- Uncorrected gross hearing, visual and/or speech impairments.
- Prone to vertigo, motion sickness, and/or migraine episodes.
- Highly physically active.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Multimodal Training
The participants in the Multimodal training arm (mBCI) will undergo 48 physical and cognitive training sessions over 24 weeks on the NeeuroCycle BCI Physical and Cognitive training system.
Sessions are scheduled three times a week for the first 12 weeks and then once a week for the subsequent 12 weeks.
Sessions are spaced at least one day apart and will take about one hour per session.The mBCI training program will deliver cognitive training modules in tandem with a stationary cycling regime.
The cognitive training program consists of six different gamified tasks that target attention, immediate/working and delayed memory, decision-making, and visuospatial abilities delivered on an electronic tablet.
The cycling regime is divided into seven non-consecutive sections.
The participant will be tasked to complete a cognitive training activity that will last about 2-3 minutes between each cycling session.
|
The NeeuroCycle Physical and Cognitive Training System is a novel multimodal electroencephalogram (EEG)-based physical and cognitive training device.
The system mainly comprises of a recumbent bicycle device and a customized four frontal electrode EEG-headband paired with the gamified NeeuroCycle cognitive training program delivered via an electronic application (app) on a tablet.
The cognitive training program is built upon patented EEG-based attention, learning, and memory algorithms.
|
EXPERIMENTAL: Neurocognitive-Training only
The participants in the Neurocognitive training-only arm (nBCI) will undergo 48 cognitive training sessions over 24 weeks on the NeeuroCycle BCI Cognitive training system.
The sessions are scheduled three times a week for the first 12 weeks and then once a week for the subsequent 12 weeks.
Sessions are spaced at least one day apart and will take about one hour per session.
The nBCI training protocol will deliver cognitive training modules that consists of six different gamified tasks that target attention, immediate/working and delayed memory, decision-making, and visuospatial abilities delivered on an electronic tablet.
Participants will navigate the virtual space of the cognitive training program by using arrow keys on the tablet.
|
The NeeuroCycle Cognitive Training System is a novel electroencephalogram (EEG)-based cognitive training device.
The system mainly comprises of a customized four frontal electrode EEG-headband paired with the gamified NeeuroCycle cognitive training program delivered via an electronic application (app) on a tablet.
The cognitive training program is built upon patented EEG-based attention, learning, and memory algorithms.
|
NO_INTERVENTION: Active Control
The participants in the Active Control arm (AC) will undergo 48 sessions over 24 weeks.
The sessions are scheduled three times a week for the first 12 weeks and then once a week for the subsequent 12 weeks.
Sessions are spaced at least one day apart and will take about one hour per session.
Participants in this arm will view informative documentaries on an electronic tablet and answer three general questions about documentary.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Repeatable Battery for the Assessement Neuropsychological Status (RBANS)
Time Frame: Comparison in the change of RBANS total score from pre-treatment (Week 1; Session 1) to mid-treatment (Week 12; Session 36) to post-treatment (Week 24; Session 48) among all three study arms.
|
The RBANS test provides reliable and well-validated assessments of five different cognitive domains including: language, attention, visuospatial awareness, immediate, and delayed memory.
|
Comparison in the change of RBANS total score from pre-treatment (Week 1; Session 1) to mid-treatment (Week 12; Session 36) to post-treatment (Week 24; Session 48) among all three study arms.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Adverse Events/Serious Adverse Events Reported
Time Frame: Throughout the intervention period (Up to 24 weeks) for all three study arms.
|
To record the number of adverse events/serious adverse events reported.
|
Throughout the intervention period (Up to 24 weeks) for all three study arms.
|
Systems Usability Scale
Time Frame: Two intervention groups(mBCI and nBCI): Post-intervention(Week 24; Session 48)
|
Participants will rate their agreeableness on 10 statements regarding their satisfaction and ease of use of the training components on a 5-point Likert scale.
Participants will also answer three qualitative questions regarding their satisfaction and ease of use.
|
Two intervention groups(mBCI and nBCI): Post-intervention(Week 24; Session 48)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tih Shih Lee, MD/PhD, Duke-NUS Graduate Medical School
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-591
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Decline
-
Jean-François DémonetUniversity of Lausanne HospitalsActive, not recruitingCognitive Performance | Functional Capacity | Subjective Cognitive Decline | Age-related Cognitive DeclineSwitzerland
-
Rotman Research Institute at BaycrestSunnybrook Health Sciences Centre; University of Waterloo; Toronto Rehabilitation... and other collaboratorsTerminatedSubjective Cognitive Decline | Age-Related Cognitive DeclineCanada
-
National Taiwan University HospitalNational Taiwan Science Education Center(NTSEC)RecruitingCognitive Training | Subjective Cognitive DeclineTaiwan
-
University of WaterlooUniversity of Ottawa; Baycrest; Université de MontréalRecruiting
-
Vanderbilt University Medical CenterNot yet recruiting
-
Indiana UniversityNational Institute on Aging (NIA)CompletedSubjective Cognitive DeclineUnited States
-
University of PrimorskaCompleted
-
Centre de Recherche de l'Institut Universitaire...Canadian Institutes of Health Research (CIHR); Rotman Research Institute at...Active, not recruitingSubjective Cognitive DeclineCanada
-
University of North Carolina, Chapel HillCompletedMild Cognitive DeclineUnited States
-
BaycrestCompletedSubjective Cognitive DeclineCanada
Clinical Trials on NeeuroCycle Physical and Cognitive Training System
-
The Hong Kong Polytechnic UniversityUniversity of Santo TomasUnknownMild Cognitive ImpairmentPhilippines
-
University Hospital, Clermont-FerrandUniversity of Clermont Auvergne (UCA) / LAPSCONot yet recruiting
-
Chiang Mai UniversityCompletedMild Cognitive ImpairmentThailand
-
Universidad Nacional de Educación a DistanciaMinistry of Economy and Competitiveness (MINECO) - Government of SpainUnknownMemory Functions | Executive FunctionsSpain
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR); Boehringer IngelheimRecruitingPulmonary Disease, Chronic ObstructiveCanada
-
National Taiwan University HospitalCompletedParkinson Disease | Mild Cognitive ImpairmentTaiwan
-
Chang Gung UniversityCompletedHealthy Older AdultsTaiwan
-
Federal University of PelotasRecruitingAging | Functional StatusBrazil
-
Aristotle University Of ThessalonikiCompleted
-
Fondazione C.N.R./Regione Toscana "G. Monasterio...UnknownDementia | Mild Cognitive Impairment | Memory DisordersItaly